instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the administration route of drug 'DOXORUBICIN'? | Survival of large volume recurrent endometrial cancer with peritoneal metastases treated by cytoreductive surgery, HIPEC and EPIC. Report of a case.
Endometrial cancer may disseminate through lymphatic channels to pelvic and retroperitoneal lymph nodes, through the bloodstream to the lungs, or through the peritoneal sp... | Intraperitoneal | DrugAdministrationRoute | CC BY-NC-ND | 33667906 | 19,025,392 | 2021-03 |
What was the administration route of drug 'IFOSFAMIDE'? | Survival of large volume recurrent endometrial cancer with peritoneal metastases treated by cytoreductive surgery, HIPEC and EPIC. Report of a case.
Endometrial cancer may disseminate through lymphatic channels to pelvic and retroperitoneal lymph nodes, through the bloodstream to the lungs, or through the peritoneal sp... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33667906 | 19,025,392 | 2021-03 |
What was the administration route of drug 'PACLITAXEL'? | Survival of large volume recurrent endometrial cancer with peritoneal metastases treated by cytoreductive surgery, HIPEC and EPIC. Report of a case.
Endometrial cancer may disseminate through lymphatic channels to pelvic and retroperitoneal lymph nodes, through the bloodstream to the lungs, or through the peritoneal sp... | Intraperitoneal | DrugAdministrationRoute | CC BY-NC-ND | 33667906 | 19,025,392 | 2021-03 |
What was the dosage of drug 'DOXORUBICIN'? | Survival of large volume recurrent endometrial cancer with peritoneal metastases treated by cytoreductive surgery, HIPEC and EPIC. Report of a case.
Endometrial cancer may disseminate through lymphatic channels to pelvic and retroperitoneal lymph nodes, through the bloodstream to the lungs, or through the peritoneal sp... | 24 mg (milligrams). | DrugDosage | CC BY-NC-ND | 33667906 | 19,025,392 | 2021-03 |
What was the dosage of drug 'IFOSFAMIDE'? | Survival of large volume recurrent endometrial cancer with peritoneal metastases treated by cytoreductive surgery, HIPEC and EPIC. Report of a case.
Endometrial cancer may disseminate through lymphatic channels to pelvic and retroperitoneal lymph nodes, through the bloodstream to the lungs, or through the peritoneal sp... | 2080 mg (milligrams). | DrugDosage | CC BY-NC-ND | 33667906 | 19,025,392 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutropenic sepsis'. | Inflammatory Breast Cancer in Men: A rare clinical case report and a literature review.
The initial misdiagnosis and delayed treatment for inflammatory breast cancer in men is brought about by its rarity and lack of readily available guidelines on pathways.
METHODS
A 78-year-old male presented to the breast clinic wi... | ALLOPURINOL, AMLODIPINE BESYLATE, CYCLOPHOSPHAMIDE, DOCETAXEL, EPIRUBICIN, FLUOROURACIL, WARFARIN | DrugsGivenReaction | CC BY-NC-ND | 33667907 | 19,094,678 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy non-responder'. | Inflammatory Breast Cancer in Men: A rare clinical case report and a literature review.
The initial misdiagnosis and delayed treatment for inflammatory breast cancer in men is brought about by its rarity and lack of readily available guidelines on pathways.
METHODS
A 78-year-old male presented to the breast clinic wi... | ALLOPURINOL, AMLODIPINE BESYLATE, TAMOXIFEN, WARFARIN | DrugsGivenReaction | CC BY-NC-ND | 33667907 | 19,168,253 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | Impact of SAfinamide on Depressive Symptoms in Parkinson's Disease Patients (SADness-PD Study): A Multicenter Retrospective Study.
BACKGROUND
We aimed to assess the effects of safinamide on depression, motor symptoms, and the serotonin syndrome related to its co-administration with antidepressants in patients with Park... | SAFINAMIDE, SERTRALINE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33668408 | 19,139,499 | 2021-02-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug interaction'. | Impact of SAfinamide on Depressive Symptoms in Parkinson's Disease Patients (SADness-PD Study): A Multicenter Retrospective Study.
BACKGROUND
We aimed to assess the effects of safinamide on depression, motor symptoms, and the serotonin syndrome related to its co-administration with antidepressants in patients with Park... | SAFINAMIDE, SERTRALINE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33668408 | 19,366,789 | 2021-02-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Labelled drug-drug interaction issue'. | Impact of SAfinamide on Depressive Symptoms in Parkinson's Disease Patients (SADness-PD Study): A Multicenter Retrospective Study.
BACKGROUND
We aimed to assess the effects of safinamide on depression, motor symptoms, and the serotonin syndrome related to its co-administration with antidepressants in patients with Park... | DULOXETINE, SAFINAMIDE, TRAMADOL | DrugsGivenReaction | CC BY | 33668408 | 19,167,920 | 2021-02-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myoclonus'. | Impact of SAfinamide on Depressive Symptoms in Parkinson's Disease Patients (SADness-PD Study): A Multicenter Retrospective Study.
BACKGROUND
We aimed to assess the effects of safinamide on depression, motor symptoms, and the serotonin syndrome related to its co-administration with antidepressants in patients with Park... | DULOXETINE, SAFINAMIDE, TRAMADOL | DrugsGivenReaction | CC BY | 33668408 | 19,139,897 | 2021-02-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nervousness'. | Impact of SAfinamide on Depressive Symptoms in Parkinson's Disease Patients (SADness-PD Study): A Multicenter Retrospective Study.
BACKGROUND
We aimed to assess the effects of safinamide on depression, motor symptoms, and the serotonin syndrome related to its co-administration with antidepressants in patients with Park... | DULOXETINE, SAFINAMIDE, TRAMADOL | DrugsGivenReaction | CC BY | 33668408 | 19,139,897 | 2021-02-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Impact of SAfinamide on Depressive Symptoms in Parkinson's Disease Patients (SADness-PD Study): A Multicenter Retrospective Study.
BACKGROUND
We aimed to assess the effects of safinamide on depression, motor symptoms, and the serotonin syndrome related to its co-administration with antidepressants in patients with Park... | DULOXETINE, SAFINAMIDE, TRAMADOL | DrugsGivenReaction | CC BY | 33668408 | 20,297,666 | 2021-02-13 |
What was the outcome of reaction 'Confusional state'? | Impact of SAfinamide on Depressive Symptoms in Parkinson's Disease Patients (SADness-PD Study): A Multicenter Retrospective Study.
BACKGROUND
We aimed to assess the effects of safinamide on depression, motor symptoms, and the serotonin syndrome related to its co-administration with antidepressants in patients with Park... | Recovering | ReactionOutcome | CC BY | 33668408 | 19,139,897 | 2021-02-13 |
What was the outcome of reaction 'Diarrhoea'? | Impact of SAfinamide on Depressive Symptoms in Parkinson's Disease Patients (SADness-PD Study): A Multicenter Retrospective Study.
BACKGROUND
We aimed to assess the effects of safinamide on depression, motor symptoms, and the serotonin syndrome related to its co-administration with antidepressants in patients with Park... | Recovering | ReactionOutcome | CC BY | 33668408 | 19,139,499 | 2021-02-13 |
What was the outcome of reaction 'Labelled drug-drug interaction issue'? | Impact of SAfinamide on Depressive Symptoms in Parkinson's Disease Patients (SADness-PD Study): A Multicenter Retrospective Study.
BACKGROUND
We aimed to assess the effects of safinamide on depression, motor symptoms, and the serotonin syndrome related to its co-administration with antidepressants in patients with Park... | Recovering | ReactionOutcome | CC BY | 33668408 | 19,167,920 | 2021-02-13 |
What was the outcome of reaction 'Myoclonus'? | Impact of SAfinamide on Depressive Symptoms in Parkinson's Disease Patients (SADness-PD Study): A Multicenter Retrospective Study.
BACKGROUND
We aimed to assess the effects of safinamide on depression, motor symptoms, and the serotonin syndrome related to its co-administration with antidepressants in patients with Park... | Recovering | ReactionOutcome | CC BY | 33668408 | 19,139,897 | 2021-02-13 |
What was the outcome of reaction 'Nervousness'? | Impact of SAfinamide on Depressive Symptoms in Parkinson's Disease Patients (SADness-PD Study): A Multicenter Retrospective Study.
BACKGROUND
We aimed to assess the effects of safinamide on depression, motor symptoms, and the serotonin syndrome related to its co-administration with antidepressants in patients with Park... | Recovering | ReactionOutcome | CC BY | 33668408 | 19,139,897 | 2021-02-13 |
What was the outcome of reaction 'Serotonin syndrome'? | Impact of SAfinamide on Depressive Symptoms in Parkinson's Disease Patients (SADness-PD Study): A Multicenter Retrospective Study.
BACKGROUND
We aimed to assess the effects of safinamide on depression, motor symptoms, and the serotonin syndrome related to its co-administration with antidepressants in patients with Park... | Recovered | ReactionOutcome | CC BY | 33668408 | 19,167,920 | 2021-02-13 |
What was the outcome of reaction 'Sleep disorder'? | Impact of SAfinamide on Depressive Symptoms in Parkinson's Disease Patients (SADness-PD Study): A Multicenter Retrospective Study.
BACKGROUND
We aimed to assess the effects of safinamide on depression, motor symptoms, and the serotonin syndrome related to its co-administration with antidepressants in patients with Park... | Recovering | ReactionOutcome | CC BY | 33668408 | 19,139,897 | 2021-02-13 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug resistance'. | The Prognostic Value of Whole-Blood PSMB5, CXCR4, POMP, and RPL5 mRNA Expression in Patients with Multiple Myeloma Treated with Bortezomib.
Proteasome inhibitors, like bortezomib, play a key role in the treatment of multiple myeloma (MM); however, most patients eventually relapse and eventually show multiple drug resis... | BORTEZOMIB | DrugsGivenReaction | CC BY | 33668794 | 19,174,581 | 2021-02-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Febrile neutropenia'. | Under-Treatment of Older Patients with Newly Diagnosed Epithelial Ovarian Cancer Remains an Issue.
Older women with ovarian cancer have disproportionately poorer survival outcomes than their younger counterparts and receive less treatment. In order to understand where the gaps lie in the treatment of older patients, st... | BEVACIZUMAB, CARBOPLATIN, DOXORUBICIN, GEMCITABINE, PACLITAXEL | DrugsGivenReaction | CC BY | 33668809 | 19,724,626 | 2021-02-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutropenia'. | Under-Treatment of Older Patients with Newly Diagnosed Epithelial Ovarian Cancer Remains an Issue.
Older women with ovarian cancer have disproportionately poorer survival outcomes than their younger counterparts and receive less treatment. In order to understand where the gaps lie in the treatment of older patients, st... | BEVACIZUMAB, CARBOPLATIN, DOXORUBICIN, GEMCITABINE, PACLITAXEL | DrugsGivenReaction | CC BY | 33668809 | 19,724,626 | 2021-02-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxicity to various agents'. | Under-Treatment of Older Patients with Newly Diagnosed Epithelial Ovarian Cancer Remains an Issue.
Older women with ovarian cancer have disproportionately poorer survival outcomes than their younger counterparts and receive less treatment. In order to understand where the gaps lie in the treatment of older patients, st... | BEVACIZUMAB, CARBOPLATIN, DOXORUBICIN, GEMCITABINE, PACLITAXEL | DrugsGivenReaction | CC BY | 33668809 | 19,724,626 | 2021-02-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pathogen resistance'. | Genetic and Phenotypic Characterization of in-Host Developed Azole-Resistant Aspergillus flavus Isolates.
Aspergillus flavus is a pathogenic fungal species that can cause pulmonary aspergillosis, and triazole compounds are used for the treatment of these infections. Prolonged exposure to azoles may select for compensat... | VORICONAZOLE | DrugsGivenReaction | CC BY | 33668871 | 19,126,259 | 2021-02-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Visual impairment'. | Genetic and Phenotypic Characterization of in-Host Developed Azole-Resistant Aspergillus flavus Isolates.
Aspergillus flavus is a pathogenic fungal species that can cause pulmonary aspergillosis, and triazole compounds are used for the treatment of these infections. Prolonged exposure to azoles may select for compensat... | VORICONAZOLE | DrugsGivenReaction | CC BY | 33668871 | 19,126,259 | 2021-02-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Tumor Type Agnostic Therapy Carrying BRAF Mutation: Case Reports and Review of Literature.
BACKGROUND
Precision medicine is based on molecular and genotypic patient characterization to define specific target treatment. BRAF mutation is an oncogenic driver, and the Cancer Genome Atlas has identified BRAF mutations in di... | BEVACIZUMAB, CARBOPLATIN, CISPLATIN, DABRAFENIB, GEMCITABINE, TRAMETINIB | DrugsGivenReaction | CC BY | 33669326 | 19,926,457 | 2021-02-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rash'. | Tumor Type Agnostic Therapy Carrying BRAF Mutation: Case Reports and Review of Literature.
BACKGROUND
Precision medicine is based on molecular and genotypic patient characterization to define specific target treatment. BRAF mutation is an oncogenic driver, and the Cancer Genome Atlas has identified BRAF mutations in di... | BEVACIZUMAB, CARBOPLATIN, CISPLATIN, DABRAFENIB, GEMCITABINE, TRAMETINIB | DrugsGivenReaction | CC BY | 33669326 | 19,926,457 | 2021-02-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect incomplete'. | Tumor Type Agnostic Therapy Carrying BRAF Mutation: Case Reports and Review of Literature.
BACKGROUND
Precision medicine is based on molecular and genotypic patient characterization to define specific target treatment. BRAF mutation is an oncogenic driver, and the Cancer Genome Atlas has identified BRAF mutations in di... | BEVACIZUMAB, CARBOPLATIN, CISPLATIN, GEMCITABINE | DrugsGivenReaction | CC BY | 33669326 | 19,897,610 | 2021-02-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy non-responder'. | Tumor Type Agnostic Therapy Carrying BRAF Mutation: Case Reports and Review of Literature.
BACKGROUND
Precision medicine is based on molecular and genotypic patient characterization to define specific target treatment. BRAF mutation is an oncogenic driver, and the Cancer Genome Atlas has identified BRAF mutations in di... | CAPECITABINE, OXALIPLATIN | DrugsGivenReaction | CC BY | 33669326 | 19,869,546 | 2021-02-16 |
What was the administration route of drug 'CAPECITABINE'? | Tumor Type Agnostic Therapy Carrying BRAF Mutation: Case Reports and Review of Literature.
BACKGROUND
Precision medicine is based on molecular and genotypic patient characterization to define specific target treatment. BRAF mutation is an oncogenic driver, and the Cancer Genome Atlas has identified BRAF mutations in di... | Oral | DrugAdministrationRoute | CC BY | 33669326 | 19,897,628 | 2021-02-16 |
What was the dosage of drug 'GEMCITABINE HYDROCHLORIDE'? | Tumor Type Agnostic Therapy Carrying BRAF Mutation: Case Reports and Review of Literature.
BACKGROUND
Precision medicine is based on molecular and genotypic patient characterization to define specific target treatment. BRAF mutation is an oncogenic driver, and the Cancer Genome Atlas has identified BRAF mutations in di... | 1250 MG/M2, CYCLIC ON DAYS 1 AND 8 | DrugDosageText | CC BY | 33669326 | 19,768,778 | 2021-02-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute kidney injury'. | Management of Anticoagulant-Related Nephropathy: A Single Center Experience.
BACKGROUND
Anticoagulant-related nephropathy (ARN) is a form of acute kidney injury that mainly occurs in patients with previously unrecognized glomerular disease in addition to excessive anticoagulation. Since a renal biopsy is not performed ... | BISOPROLOL, DABIGATRAN ETEXILATE MESYLATE, INSULIN NOS, LEVOTHYROXINE, MEMANTINE, ROSUVASTATIN, WARFARIN SODIUM | DrugsGivenReaction | CC BY | 33669373 | 15,755,299 | 2021-02-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anticoagulation drug level above therapeutic'. | Management of Anticoagulant-Related Nephropathy: A Single Center Experience.
BACKGROUND
Anticoagulant-related nephropathy (ARN) is a form of acute kidney injury that mainly occurs in patients with previously unrecognized glomerular disease in addition to excessive anticoagulation. Since a renal biopsy is not performed ... | BISOPROLOL, DABIGATRAN ETEXILATE MESYLATE, INSULIN NOS, LEVOTHYROXINE, MEMANTINE, ROSUVASTATIN, WARFARIN SODIUM | DrugsGivenReaction | CC BY | 33669373 | 15,755,299 | 2021-02-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anticoagulation drug level increased'. | Management of Anticoagulant-Related Nephropathy: A Single Center Experience.
BACKGROUND
Anticoagulant-related nephropathy (ARN) is a form of acute kidney injury that mainly occurs in patients with previously unrecognized glomerular disease in addition to excessive anticoagulation. Since a renal biopsy is not performed ... | BISOPROLOL, DABIGATRAN ETEXILATE MESYLATE, INSULIN NOS, LEVOTHYROXINE, MEMANTINE, ROSUVASTATIN, WARFARIN SODIUM | DrugsGivenReaction | CC BY | 33669373 | 15,755,299 | 2021-02-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Management of Anticoagulant-Related Nephropathy: A Single Center Experience.
BACKGROUND
Anticoagulant-related nephropathy (ARN) is a form of acute kidney injury that mainly occurs in patients with previously unrecognized glomerular disease in addition to excessive anticoagulation. Since a renal biopsy is not performed ... | BISOPROLOL, DABIGATRAN ETEXILATE MESYLATE, INSULIN NOS, LEVOTHYROXINE, MEMANTINE, ROSUVASTATIN, WARFARIN SODIUM | DrugsGivenReaction | CC BY | 33669373 | 15,755,299 | 2021-02-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Confusional state'. | Management of Anticoagulant-Related Nephropathy: A Single Center Experience.
BACKGROUND
Anticoagulant-related nephropathy (ARN) is a form of acute kidney injury that mainly occurs in patients with previously unrecognized glomerular disease in addition to excessive anticoagulation. Since a renal biopsy is not performed ... | BISOPROLOL, DABIGATRAN ETEXILATE MESYLATE, INSULIN NOS, LEVOTHYROXINE, MEMANTINE, ROSUVASTATIN, WARFARIN SODIUM | DrugsGivenReaction | CC BY | 33669373 | 15,755,299 | 2021-02-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease recurrence'. | Management of Anticoagulant-Related Nephropathy: A Single Center Experience.
BACKGROUND
Anticoagulant-related nephropathy (ARN) is a form of acute kidney injury that mainly occurs in patients with previously unrecognized glomerular disease in addition to excessive anticoagulation. Since a renal biopsy is not performed ... | BISOPROLOL, DABIGATRAN ETEXILATE MESYLATE, INSULIN NOS, LEVOTHYROXINE, MEMANTINE, ROSUVASTATIN, WARFARIN SODIUM | DrugsGivenReaction | CC BY | 33669373 | 15,755,299 | 2021-02-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastric occult blood positive'. | Management of Anticoagulant-Related Nephropathy: A Single Center Experience.
BACKGROUND
Anticoagulant-related nephropathy (ARN) is a form of acute kidney injury that mainly occurs in patients with previously unrecognized glomerular disease in addition to excessive anticoagulation. Since a renal biopsy is not performed ... | BISOPROLOL, DABIGATRAN ETEXILATE MESYLATE, INSULIN NOS, LEVOTHYROXINE, MEMANTINE, ROSUVASTATIN, WARFARIN SODIUM | DrugsGivenReaction | CC BY | 33669373 | 15,755,299 | 2021-02-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal haemorrhage'. | Management of Anticoagulant-Related Nephropathy: A Single Center Experience.
BACKGROUND
Anticoagulant-related nephropathy (ARN) is a form of acute kidney injury that mainly occurs in patients with previously unrecognized glomerular disease in addition to excessive anticoagulation. Since a renal biopsy is not performed ... | BISOPROLOL, DABIGATRAN ETEXILATE MESYLATE, INSULIN NOS, LEVOTHYROXINE, MEMANTINE, ROSUVASTATIN, WARFARIN SODIUM | DrugsGivenReaction | CC BY | 33669373 | 15,755,299 | 2021-02-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haematoma infection'. | Management of Anticoagulant-Related Nephropathy: A Single Center Experience.
BACKGROUND
Anticoagulant-related nephropathy (ARN) is a form of acute kidney injury that mainly occurs in patients with previously unrecognized glomerular disease in addition to excessive anticoagulation. Since a renal biopsy is not performed ... | BISOPROLOL, DABIGATRAN ETEXILATE MESYLATE, INSULIN NOS, LEVOTHYROXINE, MEMANTINE, ROSUVASTATIN, WARFARIN SODIUM | DrugsGivenReaction | CC BY | 33669373 | 15,755,299 | 2021-02-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemorrhage'. | Management of Anticoagulant-Related Nephropathy: A Single Center Experience.
BACKGROUND
Anticoagulant-related nephropathy (ARN) is a form of acute kidney injury that mainly occurs in patients with previously unrecognized glomerular disease in addition to excessive anticoagulation. Since a renal biopsy is not performed ... | BISOPROLOL, DABIGATRAN ETEXILATE MESYLATE, INSULIN NOS, LEVOTHYROXINE, MEMANTINE, ROSUVASTATIN, WARFARIN SODIUM | DrugsGivenReaction | CC BY | 33669373 | 15,755,299 | 2021-02-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyponatraemia'. | Management of Anticoagulant-Related Nephropathy: A Single Center Experience.
BACKGROUND
Anticoagulant-related nephropathy (ARN) is a form of acute kidney injury that mainly occurs in patients with previously unrecognized glomerular disease in addition to excessive anticoagulation. Since a renal biopsy is not performed ... | BISOPROLOL, DABIGATRAN ETEXILATE MESYLATE, INSULIN NOS, LEVOTHYROXINE, MEMANTINE, ROSUVASTATIN, WARFARIN SODIUM | DrugsGivenReaction | CC BY | 33669373 | 15,755,299 | 2021-02-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nephropathy'. | Management of Anticoagulant-Related Nephropathy: A Single Center Experience.
BACKGROUND
Anticoagulant-related nephropathy (ARN) is a form of acute kidney injury that mainly occurs in patients with previously unrecognized glomerular disease in addition to excessive anticoagulation. Since a renal biopsy is not performed ... | RIVAROXABAN | DrugsGivenReaction | CC BY | 33669373 | 19,272,482 | 2021-02-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Normocytic anaemia'. | Management of Anticoagulant-Related Nephropathy: A Single Center Experience.
BACKGROUND
Anticoagulant-related nephropathy (ARN) is a form of acute kidney injury that mainly occurs in patients with previously unrecognized glomerular disease in addition to excessive anticoagulation. Since a renal biopsy is not performed ... | BISOPROLOL, DABIGATRAN ETEXILATE MESYLATE, INSULIN NOS, LEVOTHYROXINE, MEMANTINE, ROSUVASTATIN, WARFARIN SODIUM | DrugsGivenReaction | CC BY | 33669373 | 15,755,299 | 2021-02-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Renal impairment'. | Management of Anticoagulant-Related Nephropathy: A Single Center Experience.
BACKGROUND
Anticoagulant-related nephropathy (ARN) is a form of acute kidney injury that mainly occurs in patients with previously unrecognized glomerular disease in addition to excessive anticoagulation. Since a renal biopsy is not performed ... | BISOPROLOL, DABIGATRAN ETEXILATE MESYLATE, INSULIN NOS, LEVOTHYROXINE, MEMANTINE, ROSUVASTATIN, WARFARIN SODIUM | DrugsGivenReaction | CC BY | 33669373 | 15,755,299 | 2021-02-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Septic shock'. | Management of Anticoagulant-Related Nephropathy: A Single Center Experience.
BACKGROUND
Anticoagulant-related nephropathy (ARN) is a form of acute kidney injury that mainly occurs in patients with previously unrecognized glomerular disease in addition to excessive anticoagulation. Since a renal biopsy is not performed ... | BISOPROLOL, DABIGATRAN ETEXILATE MESYLATE, INSULIN NOS, LEVOTHYROXINE, MEMANTINE, ROSUVASTATIN, WARFARIN SODIUM | DrugsGivenReaction | CC BY | 33669373 | 15,755,299 | 2021-02-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Subcapsular renal haematoma'. | Management of Anticoagulant-Related Nephropathy: A Single Center Experience.
BACKGROUND
Anticoagulant-related nephropathy (ARN) is a form of acute kidney injury that mainly occurs in patients with previously unrecognized glomerular disease in addition to excessive anticoagulation. Since a renal biopsy is not performed ... | BISOPROLOL, DABIGATRAN ETEXILATE MESYLATE, INSULIN NOS, LEVOTHYROXINE, MEMANTINE, ROSUVASTATIN, WARFARIN SODIUM | DrugsGivenReaction | CC BY | 33669373 | 15,755,299 | 2021-02-16 |
What was the administration route of drug 'DABIGATRAN ETEXILATE MESYLATE'? | Management of Anticoagulant-Related Nephropathy: A Single Center Experience.
BACKGROUND
Anticoagulant-related nephropathy (ARN) is a form of acute kidney injury that mainly occurs in patients with previously unrecognized glomerular disease in addition to excessive anticoagulation. Since a renal biopsy is not performed ... | Oral | DrugAdministrationRoute | CC BY | 33669373 | 15,755,299 | 2021-02-16 |
What was the administration route of drug 'RIVAROXABAN'? | Management of Anticoagulant-Related Nephropathy: A Single Center Experience.
BACKGROUND
Anticoagulant-related nephropathy (ARN) is a form of acute kidney injury that mainly occurs in patients with previously unrecognized glomerular disease in addition to excessive anticoagulation. Since a renal biopsy is not performed ... | Oral | DrugAdministrationRoute | CC BY | 33669373 | 19,280,908 | 2021-02-16 |
What was the administration route of drug 'WARFARIN SODIUM'? | Management of Anticoagulant-Related Nephropathy: A Single Center Experience.
BACKGROUND
Anticoagulant-related nephropathy (ARN) is a form of acute kidney injury that mainly occurs in patients with previously unrecognized glomerular disease in addition to excessive anticoagulation. Since a renal biopsy is not performed ... | Oral | DrugAdministrationRoute | CC BY | 33669373 | 15,755,299 | 2021-02-16 |
What was the dosage of drug 'DABIGATRAN ETEXILATE MESYLATE'? | Management of Anticoagulant-Related Nephropathy: A Single Center Experience.
BACKGROUND
Anticoagulant-related nephropathy (ARN) is a form of acute kidney injury that mainly occurs in patients with previously unrecognized glomerular disease in addition to excessive anticoagulation. Since a renal biopsy is not performed ... | 110 mg (milligrams). | DrugDosage | CC BY | 33669373 | 15,755,299 | 2021-02-16 |
What was the outcome of reaction 'Acute kidney injury'? | Management of Anticoagulant-Related Nephropathy: A Single Center Experience.
BACKGROUND
Anticoagulant-related nephropathy (ARN) is a form of acute kidney injury that mainly occurs in patients with previously unrecognized glomerular disease in addition to excessive anticoagulation. Since a renal biopsy is not performed ... | Recovering | ReactionOutcome | CC BY | 33669373 | 15,755,299 | 2021-02-16 |
What was the outcome of reaction 'Anticoagulation drug level above therapeutic'? | Management of Anticoagulant-Related Nephropathy: A Single Center Experience.
BACKGROUND
Anticoagulant-related nephropathy (ARN) is a form of acute kidney injury that mainly occurs in patients with previously unrecognized glomerular disease in addition to excessive anticoagulation. Since a renal biopsy is not performed ... | Recovering | ReactionOutcome | CC BY | 33669373 | 15,755,299 | 2021-02-16 |
What was the outcome of reaction 'Anticoagulation drug level increased'? | Management of Anticoagulant-Related Nephropathy: A Single Center Experience.
BACKGROUND
Anticoagulant-related nephropathy (ARN) is a form of acute kidney injury that mainly occurs in patients with previously unrecognized glomerular disease in addition to excessive anticoagulation. Since a renal biopsy is not performed ... | Recovering | ReactionOutcome | CC BY | 33669373 | 15,755,299 | 2021-02-16 |
What was the outcome of reaction 'Blood creatinine increased'? | Management of Anticoagulant-Related Nephropathy: A Single Center Experience.
BACKGROUND
Anticoagulant-related nephropathy (ARN) is a form of acute kidney injury that mainly occurs in patients with previously unrecognized glomerular disease in addition to excessive anticoagulation. Since a renal biopsy is not performed ... | Recovering | ReactionOutcome | CC BY | 33669373 | 15,755,299 | 2021-02-16 |
What was the outcome of reaction 'Condition aggravated'? | Management of Anticoagulant-Related Nephropathy: A Single Center Experience.
BACKGROUND
Anticoagulant-related nephropathy (ARN) is a form of acute kidney injury that mainly occurs in patients with previously unrecognized glomerular disease in addition to excessive anticoagulation. Since a renal biopsy is not performed ... | Fatal | ReactionOutcome | CC BY | 33669373 | 15,755,299 | 2021-02-16 |
What was the outcome of reaction 'Gastric occult blood positive'? | Management of Anticoagulant-Related Nephropathy: A Single Center Experience.
BACKGROUND
Anticoagulant-related nephropathy (ARN) is a form of acute kidney injury that mainly occurs in patients with previously unrecognized glomerular disease in addition to excessive anticoagulation. Since a renal biopsy is not performed ... | Recovering | ReactionOutcome | CC BY | 33669373 | 15,755,299 | 2021-02-16 |
What was the outcome of reaction 'Haematoma infection'? | Management of Anticoagulant-Related Nephropathy: A Single Center Experience.
BACKGROUND
Anticoagulant-related nephropathy (ARN) is a form of acute kidney injury that mainly occurs in patients with previously unrecognized glomerular disease in addition to excessive anticoagulation. Since a renal biopsy is not performed ... | Fatal | ReactionOutcome | CC BY | 33669373 | 15,755,299 | 2021-02-16 |
What was the outcome of reaction 'Nephropathy'? | Management of Anticoagulant-Related Nephropathy: A Single Center Experience.
BACKGROUND
Anticoagulant-related nephropathy (ARN) is a form of acute kidney injury that mainly occurs in patients with previously unrecognized glomerular disease in addition to excessive anticoagulation. Since a renal biopsy is not performed ... | Recovering | ReactionOutcome | CC BY | 33669373 | 19,272,482 | 2021-02-16 |
What was the outcome of reaction 'Normocytic anaemia'? | Management of Anticoagulant-Related Nephropathy: A Single Center Experience.
BACKGROUND
Anticoagulant-related nephropathy (ARN) is a form of acute kidney injury that mainly occurs in patients with previously unrecognized glomerular disease in addition to excessive anticoagulation. Since a renal biopsy is not performed ... | Recovering | ReactionOutcome | CC BY | 33669373 | 15,755,299 | 2021-02-16 |
What was the outcome of reaction 'Renal impairment'? | Management of Anticoagulant-Related Nephropathy: A Single Center Experience.
BACKGROUND
Anticoagulant-related nephropathy (ARN) is a form of acute kidney injury that mainly occurs in patients with previously unrecognized glomerular disease in addition to excessive anticoagulation. Since a renal biopsy is not performed ... | Recovering | ReactionOutcome | CC BY | 33669373 | 15,755,299 | 2021-02-16 |
What was the outcome of reaction 'Renal tubular injury'? | Management of Anticoagulant-Related Nephropathy: A Single Center Experience.
BACKGROUND
Anticoagulant-related nephropathy (ARN) is a form of acute kidney injury that mainly occurs in patients with previously unrecognized glomerular disease in addition to excessive anticoagulation. Since a renal biopsy is not performed ... | Recovering | ReactionOutcome | CC BY | 33669373 | 15,755,299 | 2021-02-16 |
What was the outcome of reaction 'Septic shock'? | Management of Anticoagulant-Related Nephropathy: A Single Center Experience.
BACKGROUND
Anticoagulant-related nephropathy (ARN) is a form of acute kidney injury that mainly occurs in patients with previously unrecognized glomerular disease in addition to excessive anticoagulation. Since a renal biopsy is not performed ... | Fatal | ReactionOutcome | CC BY | 33669373 | 15,755,299 | 2021-02-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy partial responder'. | Murine Typhus Infection in Pregnancy: Case Series and Literature Review.
Murine typhus is a flea-borne disease of worldwide distribution with a recent reemergence in the United States of America. There are limited data about the presentation, treatment, and outcomes in the pregnant population. We report on two cases of... | ACETAMINOPHEN, AZITHROMYCIN ANHYDROUS, CEFTRIAXONE, FUROSEMIDE | DrugsGivenReaction | CC BY | 33670581 | 19,364,152 | 2021-02-18 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Osteonecrosis of jaw'. | Partial and Total Flap Failure after Fibula Free Flap in Head and Neck Reconstructive Surgery: Retrospective Analysis of 180 Flaps over 19 Years.
Fibula free flap (FFF) is widely used in head and neck reconstructive surgery and is considered as a standard and therapy of choice after ablative cancer surgery. The aim of ... | DENOSUMAB, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY | 33670721 | 19,661,708 | 2021-02-18 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pathological fracture'. | Partial and Total Flap Failure after Fibula Free Flap in Head and Neck Reconstructive Surgery: Retrospective Analysis of 180 Flaps over 19 Years.
Fibula free flap (FFF) is widely used in head and neck reconstructive surgery and is considered as a standard and therapy of choice after ablative cancer surgery. The aim of ... | DENOSUMAB, ZOLEDRONIC ACID | DrugsGivenReaction | CC BY | 33670721 | 19,661,708 | 2021-02-18 |
What was the outcome of reaction 'Osteonecrosis of jaw'? | Partial and Total Flap Failure after Fibula Free Flap in Head and Neck Reconstructive Surgery: Retrospective Analysis of 180 Flaps over 19 Years.
Fibula free flap (FFF) is widely used in head and neck reconstructive surgery and is considered as a standard and therapy of choice after ablative cancer surgery. The aim of ... | Recovering | ReactionOutcome | CC BY | 33670721 | 19,661,708 | 2021-02-18 |
What was the outcome of reaction 'Pathological fracture'? | Partial and Total Flap Failure after Fibula Free Flap in Head and Neck Reconstructive Surgery: Retrospective Analysis of 180 Flaps over 19 Years.
Fibula free flap (FFF) is widely used in head and neck reconstructive surgery and is considered as a standard and therapy of choice after ablative cancer surgery. The aim of ... | Recovering | ReactionOutcome | CC BY | 33670721 | 19,661,708 | 2021-02-18 |
What was the administration route of drug 'ALENDRONATE SODIUM'? | Conservative Management of Medication-Related Osteonecrosis of the Jaws (MRONJ): A Retrospective Cohort Study.
BACKGROUND
Medication-related osteonecrosis of the jaw (MRONJ) is a severe side effect of bisphosphonates and anti-resorptive drugs prescribed for treatment of severe osteoporosis, Paget's disease, and bone ma... | Oral | DrugAdministrationRoute | CC BY | 33671429 | 19,769,348 | 2021-02-17 |
What was the administration route of drug 'ALENDRONIC ACID'? | Conservative Management of Medication-Related Osteonecrosis of the Jaws (MRONJ): A Retrospective Cohort Study.
BACKGROUND
Medication-related osteonecrosis of the jaw (MRONJ) is a severe side effect of bisphosphonates and anti-resorptive drugs prescribed for treatment of severe osteoporosis, Paget's disease, and bone ma... | Oral | DrugAdministrationRoute | CC BY | 33671429 | 19,071,547 | 2021-02-17 |
What was the administration route of drug 'CHLORHEXIDINE'? | Conservative Management of Medication-Related Osteonecrosis of the Jaws (MRONJ): A Retrospective Cohort Study.
BACKGROUND
Medication-related osteonecrosis of the jaw (MRONJ) is a severe side effect of bisphosphonates and anti-resorptive drugs prescribed for treatment of severe osteoporosis, Paget's disease, and bone ma... | Topical | DrugAdministrationRoute | CC BY | 33671429 | 19,071,547 | 2021-02-17 |
What was the dosage of drug 'ALENDRONATE SODIUM'? | Conservative Management of Medication-Related Osteonecrosis of the Jaws (MRONJ): A Retrospective Cohort Study.
BACKGROUND
Medication-related osteonecrosis of the jaw (MRONJ) is a severe side effect of bisphosphonates and anti-resorptive drugs prescribed for treatment of severe osteoporosis, Paget's disease, and bone ma... | ALENDRONATE (24 MONTHS) | DrugDosageText | CC BY | 33671429 | 19,769,348 | 2021-02-17 |
What was the outcome of reaction 'Surgery'? | Conservative Management of Medication-Related Osteonecrosis of the Jaws (MRONJ): A Retrospective Cohort Study.
BACKGROUND
Medication-related osteonecrosis of the jaw (MRONJ) is a severe side effect of bisphosphonates and anti-resorptive drugs prescribed for treatment of severe osteoporosis, Paget's disease, and bone ma... | Recovered | ReactionOutcome | CC BY | 33671429 | 19,071,547 | 2021-02-17 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory failure'. | Pearls and Pitfalls of Introducing Ketogenic Diet in Adult Status Epilepticus: A Practical Guide for the Intensivist.
Background: Status epilepticus (SE) carries an exceedingly high mortality and morbidity, often warranting an aggressive therapeutic approach. Recently, the implementation of a ketogenic diet (KD) in adu... | ACYCLOVIR, LEVETIRACETAM, LORAZEPAM, PENTOBARBITAL, PHENYTOIN, PROPOFOL, VALPROIC ACID | DrugsGivenReaction | CC BY | 33671485 | 19,466,490 | 2021-02-22 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Seizure'. | Pearls and Pitfalls of Introducing Ketogenic Diet in Adult Status Epilepticus: A Practical Guide for the Intensivist.
Background: Status epilepticus (SE) carries an exceedingly high mortality and morbidity, often warranting an aggressive therapeutic approach. Recently, the implementation of a ketogenic diet (KD) in adu... | ACYCLOVIR, LEVETIRACETAM, LORAZEPAM, PENTOBARBITAL, PHENYTOIN, PROPOFOL, VALPROIC ACID | DrugsGivenReaction | CC BY | 33671485 | 19,466,490 | 2021-02-22 |
What was the administration route of drug 'LORAZEPAM'? | Pearls and Pitfalls of Introducing Ketogenic Diet in Adult Status Epilepticus: A Practical Guide for the Intensivist.
Background: Status epilepticus (SE) carries an exceedingly high mortality and morbidity, often warranting an aggressive therapeutic approach. Recently, the implementation of a ketogenic diet (KD) in adu... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33671485 | 19,466,490 | 2021-02-22 |
What was the dosage of drug 'ACYCLOVIR'? | Pearls and Pitfalls of Introducing Ketogenic Diet in Adult Status Epilepticus: A Practical Guide for the Intensivist.
Background: Status epilepticus (SE) carries an exceedingly high mortality and morbidity, often warranting an aggressive therapeutic approach. Recently, the implementation of a ketogenic diet (KD) in adu... | UNKNOWN DOSE | DrugDosageText | CC BY | 33671485 | 19,466,490 | 2021-02-22 |
What was the dosage of drug 'LEVETIRACETAM'? | Pearls and Pitfalls of Introducing Ketogenic Diet in Adult Status Epilepticus: A Practical Guide for the Intensivist.
Background: Status epilepticus (SE) carries an exceedingly high mortality and morbidity, often warranting an aggressive therapeutic approach. Recently, the implementation of a ketogenic diet (KD) in adu... | UNKNOWN DOSE | DrugDosageText | CC BY | 33671485 | 19,466,490 | 2021-02-22 |
What was the dosage of drug 'LORAZEPAM'? | Pearls and Pitfalls of Introducing Ketogenic Diet in Adult Status Epilepticus: A Practical Guide for the Intensivist.
Background: Status epilepticus (SE) carries an exceedingly high mortality and morbidity, often warranting an aggressive therapeutic approach. Recently, the implementation of a ketogenic diet (KD) in adu... | 2 MILLIGRAM, UNK | DrugDosageText | CC BY | 33671485 | 19,466,490 | 2021-02-22 |
What was the dosage of drug 'PROPOFOL'? | Pearls and Pitfalls of Introducing Ketogenic Diet in Adult Status Epilepticus: A Practical Guide for the Intensivist.
Background: Status epilepticus (SE) carries an exceedingly high mortality and morbidity, often warranting an aggressive therapeutic approach. Recently, the implementation of a ketogenic diet (KD) in adu... | UNKNOWN DOSE | DrugDosageText | CC BY | 33671485 | 19,466,490 | 2021-02-22 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood lactate dehydrogenase increased'. | Histiocytic Sarcoma: Challenging Course, Dismal Outcome.
Histiocytic sarcoma (HS) is a rare hematopoietic neoplasm derived from non-Langerhans histiocytic cells of the monocyte/macrophage system. With an incidence of 0.17/million individuals and a slight male preference, HS presents with a wide age distribution. Most c... | CYTARABINE, FILGRASTIM, FLUDARABINE PHOSPHATE, HYDROXYUREA, IDARUBICIN | DrugsGivenReaction | CC BY | 33671860 | 19,961,558 | 2021-02-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bone pain'. | Histiocytic Sarcoma: Challenging Course, Dismal Outcome.
Histiocytic sarcoma (HS) is a rare hematopoietic neoplasm derived from non-Langerhans histiocytic cells of the monocyte/macrophage system. With an incidence of 0.17/million individuals and a slight male preference, HS presents with a wide age distribution. Most c... | CYTARABINE, FILGRASTIM, FLUDARABINE PHOSPHATE, HYDROXYUREA, IDARUBICIN | DrugsGivenReaction | CC BY | 33671860 | 19,961,558 | 2021-02-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Histiocytic Sarcoma: Challenging Course, Dismal Outcome.
Histiocytic sarcoma (HS) is a rare hematopoietic neoplasm derived from non-Langerhans histiocytic cells of the monocyte/macrophage system. With an incidence of 0.17/million individuals and a slight male preference, HS presents with a wide age distribution. Most c... | CYTARABINE, FILGRASTIM, FLUDARABINE PHOSPHATE, HYDROXYUREA, IDARUBICIN | DrugsGivenReaction | CC BY | 33671860 | 19,961,558 | 2021-02-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytopenia'. | Histiocytic Sarcoma: Challenging Course, Dismal Outcome.
Histiocytic sarcoma (HS) is a rare hematopoietic neoplasm derived from non-Langerhans histiocytic cells of the monocyte/macrophage system. With an incidence of 0.17/million individuals and a slight male preference, HS presents with a wide age distribution. Most c... | CYTARABINE, FILGRASTIM, FLUDARABINE PHOSPHATE, HYDROXYUREA, IDARUBICIN | DrugsGivenReaction | CC BY | 33671860 | 19,961,558 | 2021-02-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fatigue'. | Histiocytic Sarcoma: Challenging Course, Dismal Outcome.
Histiocytic sarcoma (HS) is a rare hematopoietic neoplasm derived from non-Langerhans histiocytic cells of the monocyte/macrophage system. With an incidence of 0.17/million individuals and a slight male preference, HS presents with a wide age distribution. Most c... | CYTARABINE, FILGRASTIM, FLUDARABINE PHOSPHATE, HYDROXYUREA, IDARUBICIN | DrugsGivenReaction | CC BY | 33671860 | 19,961,558 | 2021-02-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pyrexia'. | Histiocytic Sarcoma: Challenging Course, Dismal Outcome.
Histiocytic sarcoma (HS) is a rare hematopoietic neoplasm derived from non-Langerhans histiocytic cells of the monocyte/macrophage system. With an incidence of 0.17/million individuals and a slight male preference, HS presents with a wide age distribution. Most c... | CYTARABINE, FILGRASTIM, FLUDARABINE PHOSPHATE, HYDROXYUREA, IDARUBICIN | DrugsGivenReaction | CC BY | 33671860 | 19,961,558 | 2021-02-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic response shortened'. | Histiocytic Sarcoma: Challenging Course, Dismal Outcome.
Histiocytic sarcoma (HS) is a rare hematopoietic neoplasm derived from non-Langerhans histiocytic cells of the monocyte/macrophage system. With an incidence of 0.17/million individuals and a slight male preference, HS presents with a wide age distribution. Most c... | CYTARABINE, FILGRASTIM, FLUDARABINE PHOSPHATE, HYDROXYUREA, IDARUBICIN | DrugsGivenReaction | CC BY | 33671860 | 19,961,558 | 2021-02-15 |
What was the outcome of reaction 'Condition aggravated'? | Histiocytic Sarcoma: Challenging Course, Dismal Outcome.
Histiocytic sarcoma (HS) is a rare hematopoietic neoplasm derived from non-Langerhans histiocytic cells of the monocyte/macrophage system. With an incidence of 0.17/million individuals and a slight male preference, HS presents with a wide age distribution. Most c... | Fatal | ReactionOutcome | CC BY | 33671860 | 19,961,558 | 2021-02-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Atrial thrombosis'. | Percutaneous Occlusion of the Left Atrial Appendage with Thrombus Irresponsive to Antithrombotic Therapy.
We analyzed clinical experience with percutaneous closure of instances of left atrial appendage with thrombus (LAAT) irresponsive to antithrombotic therapy in patients treated in three high-volume cardiology center... | RIVAROXABAN | DrugsGivenReaction | CC BY | 33673147 | 19,055,045 | 2021-02-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Percutaneous Occlusion of the Left Atrial Appendage with Thrombus Irresponsive to Antithrombotic Therapy.
We analyzed clinical experience with percutaneous closure of instances of left atrial appendage with thrombus (LAAT) irresponsive to antithrombotic therapy in patients treated in three high-volume cardiology center... | RIVAROXABAN | DrugsGivenReaction | CC BY | 33673147 | 19,055,045 | 2021-02-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal haemorrhage'. | Percutaneous Occlusion of the Left Atrial Appendage with Thrombus Irresponsive to Antithrombotic Therapy.
We analyzed clinical experience with percutaneous closure of instances of left atrial appendage with thrombus (LAAT) irresponsive to antithrombotic therapy in patients treated in three high-volume cardiology center... | RIVAROXABAN | DrugsGivenReaction | CC BY | 33673147 | 19,055,045 | 2021-02-12 |
What was the administration route of drug 'RIVAROXABAN'? | Percutaneous Occlusion of the Left Atrial Appendage with Thrombus Irresponsive to Antithrombotic Therapy.
We analyzed clinical experience with percutaneous closure of instances of left atrial appendage with thrombus (LAAT) irresponsive to antithrombotic therapy in patients treated in three high-volume cardiology center... | Oral | DrugAdministrationRoute | CC BY | 33673147 | 19,055,045 | 2021-02-12 |
What was the administration route of drug 'BACLOFEN'? | Botulinum Neurotoxin Injections in Childhood Opisthotonus.
Opisthotonus refers to abnormal axial extension and arching of the trunk produced by excessive contractions of the paraspinal muscles. In childhood, the abnormal posture is most often related to dystonia in the setting of hypoxic injury or a number of other acq... | Oral | DrugAdministrationRoute | CC BY | 33673369 | 19,648,953 | 2021-02-12 |
What was the administration route of drug 'CLONAZEPAM'? | Botulinum Neurotoxin Injections in Childhood Opisthotonus.
Opisthotonus refers to abnormal axial extension and arching of the trunk produced by excessive contractions of the paraspinal muscles. In childhood, the abnormal posture is most often related to dystonia in the setting of hypoxic injury or a number of other acq... | Oral | DrugAdministrationRoute | CC BY | 33673369 | 19,648,953 | 2021-02-12 |
What was the administration route of drug 'CLONIDINE'? | Botulinum Neurotoxin Injections in Childhood Opisthotonus.
Opisthotonus refers to abnormal axial extension and arching of the trunk produced by excessive contractions of the paraspinal muscles. In childhood, the abnormal posture is most often related to dystonia in the setting of hypoxic injury or a number of other acq... | Oral | DrugAdministrationRoute | CC BY | 33673369 | 19,648,951 | 2021-02-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Adrenal insufficiency'. | Immune-Related Adverse Events (irAE) in Cancer Immune Checkpoint Inhibitors (ICI) and Survival Outcomes Correlation: To Rechallenge or Not?
BACKGROUND
There is growing recognition of immune related adverse events (irAEs) from immune checkpoint therapies being correlated with treatment outcomes in certain malignancies. ... | ATEZOLIZUMAB, AVELUMAB, DURVALUMAB, IPILIMUMAB, NIVOLUMAB, PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 33673446 | 19,761,769 | 2021-02-27 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Arthralgia'. | Immune-Related Adverse Events (irAE) in Cancer Immune Checkpoint Inhibitors (ICI) and Survival Outcomes Correlation: To Rechallenge or Not?
BACKGROUND
There is growing recognition of immune related adverse events (irAEs) from immune checkpoint therapies being correlated with treatment outcomes in certain malignancies. ... | ATEZOLIZUMAB, AVELUMAB, DURVALUMAB, IPILIMUMAB, NIVOLUMAB, PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 33673446 | 19,761,769 | 2021-02-27 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diabetes mellitus'. | Immune-Related Adverse Events (irAE) in Cancer Immune Checkpoint Inhibitors (ICI) and Survival Outcomes Correlation: To Rechallenge or Not?
BACKGROUND
There is growing recognition of immune related adverse events (irAEs) from immune checkpoint therapies being correlated with treatment outcomes in certain malignancies. ... | ATEZOLIZUMAB, AVELUMAB, DURVALUMAB, IPILIMUMAB, NIVOLUMAB, PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 33673446 | 19,761,769 | 2021-02-27 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | Immune-Related Adverse Events (irAE) in Cancer Immune Checkpoint Inhibitors (ICI) and Survival Outcomes Correlation: To Rechallenge or Not?
BACKGROUND
There is growing recognition of immune related adverse events (irAEs) from immune checkpoint therapies being correlated with treatment outcomes in certain malignancies. ... | ATEZOLIZUMAB, AVELUMAB, DURVALUMAB, IPILIMUMAB, NIVOLUMAB, PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 33673446 | 19,761,769 | 2021-02-27 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.